• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于靶向溶栓的壳聚糖纳米复合材料对重组组织型纤溶酶原激活剂的磁控释放。

Magnetically controlled release of recombinant tissue plasminogen activator from chitosan nanocomposites for targeted thrombolysis.

作者信息

Chen Jyh-Ping, Liu Chih-Hsin, Hsu Hao-Lung, Wu Tony, Lu Yu-Jen, Ma Yunn-Hwa

机构信息

Department of Chemical and Materials Engineering and Biomedical Engineering Research Center, Chang Gung University, Kwei-San, Taoyuan 333, Taiwan, Republic of China.

出版信息

J Mater Chem B. 2016 Apr 21;4(15):2578-2590. doi: 10.1039/c5tb02579f. Epub 2016 Mar 24.

DOI:10.1039/c5tb02579f
PMID:32263281
Abstract

Ionic cross-linking of water-soluble chitosan with sodium tripolyphosphate in the presence of recombinant tissue plasminogen activator (rtPA) and magnetite (FeO) nanoparticles could produce rtPA-encapsulated magnetic chitosan nanoparticles (MCNPs-rtPA). MCNPs do not elicit cytotoxicity and hemolysis in vitro. MCNPs-rtPA showed a negligible release of the rtPA protein when stored in phosphate buffer for 28 days. In contrast, the burst release of rtPA from MCNPs-rtPA was found in the serum with 60% of the original activity released in 30 min. The drug release into the serum is also magnet-sensitive; the release could be turned down with a magnetic field when MCNPs-rtPA was pelleted and reversibly turned on after removing the magnetic field when MCNPs-rtPA was dispersed. An in vitro thrombolytic study by thromboelastometry indicated a controlled release of rtPA from MCNPs-rtPA. In a rat embolic model where a preformed blood clot lodged in the left iliac artery upstream of the pudic epigastric branch, MCNPs-rtPA (0.2 mg kg rtPA) was administered and guided magnetically to the clot, followed by mobile magnetic guidance for 60 min. Iliac blood flow increased immediately in response to the treatment, and reached a stable level ∼50 min after drug administration and the hind limb perfusion rate was restored from 53% to 75% of the basal level. Effective thrombolysis was therefore successfully demonstrated at an rtPA dose equivalent to 20% of the regular dose when the MCNPs-rtPA pellet was magnet-guided to the blood clot, followed by a triggered release of rtPA when switched to mobile magnetic guidance.

摘要

在重组组织型纤溶酶原激活剂(rtPA)和磁铁矿(FeO)纳米颗粒存在的情况下,水溶性壳聚糖与三聚磷酸钠进行离子交联可制备包载rtPA的磁性壳聚糖纳米颗粒(MCNPs-rtPA)。MCNPs在体外不会引起细胞毒性和溶血。MCNPs-rtPA在磷酸盐缓冲液中储存28天时,rtPA蛋白的释放量可忽略不计。相比之下,在血清中发现MCNPs-rtPA会出现rtPA的突释,30分钟内释放出60%的原始活性。药物向血清中的释放也具有磁敏感性;当MCNPs-rtPA形成沉淀时,施加磁场可使释放量降低,而去除磁场使MCNPs-rtPA分散后,释放又会可逆地开启。通过血栓弹力测定法进行的体外溶栓研究表明,rtPA从MCNPs-rtPA中可控释放。在一个大鼠栓塞模型中,预先形成的血凝块位于阴部腹壁分支上游的左髂动脉中,给予MCNPs-rtPA(0.2 mg/kg rtPA)并通过磁力引导至血凝块处,随后进行60分钟的移动磁引导。治疗后髂动脉血流量立即增加,给药后约50分钟达到稳定水平,后肢灌注率从基础水平的53%恢复到75%。因此,当MCNPs-rtPA沉淀被磁引导至血凝块处,随后切换至移动磁引导时触发rtPA释放,成功证明了在rtPA剂量相当于常规剂量20%时的有效溶栓效果。

相似文献

1
Magnetically controlled release of recombinant tissue plasminogen activator from chitosan nanocomposites for targeted thrombolysis.用于靶向溶栓的壳聚糖纳米复合材料对重组组织型纤溶酶原激活剂的磁控释放。
J Mater Chem B. 2016 Apr 21;4(15):2578-2590. doi: 10.1039/c5tb02579f. Epub 2016 Mar 24.
2
Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.肽和重组组织型纤溶酶原激活物偶联聚乳酸-羟基乙酸共聚物(PLGA)磁性纳米颗粒的制备及其用于双重靶向溶栓治疗。
Int J Mol Sci. 2020 Apr 13;21(8):2690. doi: 10.3390/ijms21082690.
3
Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles.结合于聚丙烯酸包被纳米颗粒的重组组织型纤溶酶原激活剂的磁靶向溶栓治疗
Biomaterials. 2009 Jul;30(19):3343-51. doi: 10.1016/j.biomaterials.2009.02.034. Epub 2009 Mar 18.
4
Thrombolysis induced by intravenous administration of plasminogen activator in magnetoliposomes: dual targeting by magnetic and thermal manipulation.静脉注射载血纤维蛋白溶酶原激活物的磁脂质体溶栓:磁热双重靶向治疗。
Nanomedicine. 2019 Aug;20:101992. doi: 10.1016/j.nano.2019.03.014. Epub 2019 Apr 11.
5
Targeted Thrombolysis with Magnetic Nanotherapeutics: A Translational Assessment.磁性纳米疗法靶向溶栓:一项转化评估。
Pharmaceutics. 2024 Apr 27;16(5):596. doi: 10.3390/pharmaceutics16050596.
6
Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis.将重组组织型纤溶酶原激活物偶联到磁性纳米载体用于靶向溶栓。
Int J Nanomedicine. 2012;7:5159-73. doi: 10.2147/IJN.S32939. Epub 2012 Oct 1.
7
Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.载有 rtPA 的基于 Fe₃O₄ 的 PLGA 纳米粒子的构建和评价用于血栓的检测和靶向溶栓。
ACS Appl Mater Interfaces. 2014 Apr 23;6(8):5566-76. doi: 10.1021/am406008k. Epub 2014 Apr 2.
8
Recombinant Tissue Plasminogen Activator-conjugated Nanoparticles Effectively Targets Thrombolysis in a Rat Model of Middle Cerebral Artery Occlusion.载重组组织型纤溶酶原激活物的纳米颗粒在大脑中动脉闭塞大鼠模型中具有有效的溶栓靶向作用。
Curr Med Sci. 2018 Jun;38(3):427-435. doi: 10.1007/s11596-018-1896-z. Epub 2018 Jun 22.
9
Optimizing coronary thrombolysis with i.v. administration of recombinant tissue plasminogen activator. Single bolus vs double bolus vs front-loading.静脉注射重组组织型纤溶酶原激活剂优化冠状动脉溶栓治疗。单次推注与两次推注与负荷剂量法。
Chest. 1996 Feb;109(2):510-5. doi: 10.1378/chest.109.2.510.
10
Coronary thrombolysis. Comparative effects of intracoronary administration of recombinant tissue plasminogen activator and urokinase.冠状动脉溶栓。冠状动脉内注射重组组织型纤溶酶原激活剂与尿激酶的比较效果。
Chest. 1992 Jun;101(6):1684-90. doi: 10.1378/chest.101.6.1684.

引用本文的文献

1
Emerging Elastic Micro-Nano Materials for Diagnosis and Treatment of Thrombosis.用于血栓诊断与治疗的新型弹性微纳材料
Research (Wash D C). 2025 Feb 28;8:0614. doi: 10.34133/research.0614. eCollection 2025.
2
Overview of Venous Thromboembolism and Emerging Therapeutic Technologies Based on Nanocarriers-Mediated Drug Delivery Systems.静脉血栓栓塞症概述及基于纳米载体药物传递系统的新兴治疗技术
Molecules. 2024 Oct 15;29(20):4883. doi: 10.3390/molecules29204883.
3
Targeted thrombolysis by magnetoacoustic particles in photothrombotic stroke model.
光血栓性中风模型中磁声颗粒的靶向溶栓作用
Biomater Res. 2022 Oct 22;26(1):58. doi: 10.1186/s40824-022-00298-y.
4
Iron Oxide Nanoparticles in Regenerative Medicine and Tissue Engineering.再生医学与组织工程中的氧化铁纳米颗粒
Nanomaterials (Basel). 2021 Sep 8;11(9):2337. doi: 10.3390/nano11092337.
5
New Approaches in Nanomedicine for Ischemic Stroke.纳米医学治疗缺血性中风的新方法
Pharmaceutics. 2021 May 20;13(5):757. doi: 10.3390/pharmaceutics13050757.
6
Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke.靶向纳米递药策略促进缺血性脑卒中的溶栓治疗。
Drug Deliv. 2021 Dec;28(1):357-371. doi: 10.1080/10717544.2021.1879315.
7
Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy.肽和重组组织型纤溶酶原激活物偶联聚乳酸-羟基乙酸共聚物(PLGA)磁性纳米颗粒的制备及其用于双重靶向溶栓治疗。
Int J Mol Sci. 2020 Apr 13;21(8):2690. doi: 10.3390/ijms21082690.
8
Synthesis and evaluation of cationic polymeric micelles as carriers of lumbrokinase for targeted thrombolysis.阳离子聚合物胶束作为蚓激酶靶向溶栓载体的合成与评价
Asian J Pharm Sci. 2019 Mar;14(2):144-153. doi: 10.1016/j.ajps.2018.03.004. Epub 2018 May 16.
9
Targeted Delivery of Plasminogen Activators for Thrombolytic Therapy: An Integrative Evaluation.靶向递送纤溶酶原激活剂用于溶栓治疗:综合评价。
Molecules. 2019 Sep 19;24(18):3407. doi: 10.3390/molecules24183407.
10
Effects of PEGylation on capture of dextran-coated magnetic nanoparticles in microcirculation.聚乙二醇化对微循环中葡聚糖涂层磁性纳米粒子捕获的影响。
Int J Nanomedicine. 2019 Jul 3;14:4767-4780. doi: 10.2147/IJN.S204844. eCollection 2019.